Ozempic among drugs targeted in upcoming Medicare price negotiations
Novo Nordisk’s blockbuster diabetes and weight-loss drugs Ozempic and Wegovy are among a group of 15 drugs set to be affected by the next round of US government price negotiations by Medicare. The group of drugs accounted for about $41bn in annual spending by Medicare,
The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level ...
The CMS administrator highlighted her agency’s efforts to help states fast-track Medicaid renewals — and warned of walking ...
The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...
"If CMS reduces it below 90%, I will be the first to push to eliminate, as that was not the deal we made," said Rep. Donny ...
CMS has been dedicated to strengthening Medicaid and CHIP by helping eligible people more easily enroll and keep their ...
Alignment Healthcare is the latest Medicare Advantage (MA) insurer to accuse the Centers for Medicare & Medicaid Services ...
How the FDA and CMS worked together on a new approach to paying for digital mental health treatments
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
This explainer defines Medicaid work requirements, updates their current status at the federal and state levels, and ...
When it comes to ensuring patient safety, healthcare facilities operate under a complex regulatory framework, including ...
The Centers for Medicare & Medicaid Services Jan. 13 released its standards for the health insurance marketplaces for 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback